(+)-pilocarpine multiple interactions EXP 6480464 [Lithium co-treated with Pilocarpine] results in decreased expression of GRIA3 mRNA CTD PMID:16819974 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GRIA3 mRNA, Pilocarpine results in increased expression of GRIA3 protein CTD PMID:15857427 , PMID:7529610 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of GRIA3 mRNA CTD PMID:7529610 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile affects response to substance ISO RGD:737336 6480464 GRIA3 polymorphism affects the susceptibility to Citalopram CTD PMID:19295509 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of GRIA3 mRNA CTD PMID:17070881 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GRIA3 mRNA CTD PMID:26496021 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737336 6480464 Tetrachlorodibenzodioxin affects the expression of GRIA3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GRIA3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GRIA3 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737336 6480464 Tetrachlorodibenzodioxin results in increased expression of GRIA3 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737337 6480464 Tetrachlorodibenzodioxin affects the expression of GRIA3 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of GRIA3 mRNA CTD PMID:17070881 2,6-diaminotoluene decreases expression EXP 6480464 2, 6-diaminotoluene results in decreased expression of GRIA3 mRNA CTD PMID:17070881 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of GRIA3 mRNA CTD PMID:17070881 2-acetamidofluorene increases expression ISO RGD:737337 6480464 2-Acetylaminofluorene results in increased expression of GRIA3 mRNA CTD PMID:21607683 2-nitro-p-phenylenediamine increases expression EXP 6480464 2-nitro-4-phenylenediamine results in increased expression of GRIA3 mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of GRIA3 mRNA CTD PMID:22484513 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of GRIA3 mRNA CTD PMID:17070881 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of GRIA3 mRNA CTD PMID:30071829 3-(5-fluorouracil-1-yl)-L-alanine affects response to substance ISO RGD:737337 6480464 GRIA3 protein affects the susceptibility to 5-fluorowillardiine CTD PMID:15264227 3-methylcholanthrene multiple interactions ISO RGD:737337 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GRIA3 mRNA CTD PMID:23519560 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GRIA3 mRNA CTD PMID:22484513 4-acetylaminofluorene decreases expression EXP 6480464 4-acetylaminofluorene results in decreased expression of GRIA3 mRNA CTD PMID:17070881 4-nitro-1,2-phenylenediamine decreases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of GRIA3 mRNA CTD PMID:17070881 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GRIA3 mRNA CTD PMID:24780913 6-propyl-2-thiouracil multiple interactions EXP 6480464 isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA] CTD PMID:31068541 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GRIA3 mRNA CTD PMID:31068541 acetamide increases expression EXP 6480464 acetamide results in increased expression of GRIA3 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GRIA3 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GRIA3 mRNA CTD PMID:22484513 more ... aflatoxin B1 increases expression ISO RGD:737336 6480464 Aflatoxin B1 results in increased expression of GRIA3 mRNA CTD PMID:32234424 aflatoxin B1 decreases methylation ISO RGD:737336 6480464 Aflatoxin B1 results in decreased methylation of GRIA3 gene CTD PMID:27153756 aldrin increases expression ISO RGD:737337 6480464 Aldrin results in increased expression of GRIA3 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:737336 6480464 Tretinoin results in decreased expression of GRIA3 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:737336 6480464 Tretinoin results in increased expression of GRIA3 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of GRIA3 mRNA CTD PMID:20488242 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GRIA3 mRNA CTD PMID:16483693 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of GRIA3 mRNA CTD PMID:23038007 arotinoid acid multiple interactions ISO RGD:737336 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsenite(3-) increases expression ISO RGD:737337 6480464 arsenite results in increased expression of GRIA3 mRNA CTD PMID:33053406 arsenite(3-) decreases expression ISO RGD:737337 6480464 arsenite results in decreased expression of GRIA3 mRNA, arsenite results in decreased expression of GRIA3 protein CTD PMID:31708534 belinostat increases expression ISO RGD:737336 6480464 belinostat results in increased expression of GRIA3 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of GRIA3 mRNA CTD PMID:21839799 benzo[a]pyrene decreases methylation ISO RGD:737337 6480464 Benzo(a)pyrene results in decreased methylation of GRIA3 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:737337 6480464 Benzo(a)pyrene results in increased expression of GRIA3 mRNA CTD PMID:21964900 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:737336 6480464 Benzo(a)pyrene results in increased expression of GRIA3 mRNA CTD PMID:20106945 , PMID:22316170 benzo[b]fluoranthene increases expression ISO RGD:737337 6480464 benzo(b)fluoranthene results in increased expression of GRIA3 mRNA CTD PMID:26377693 benzoates multiple interactions EXP 6480464 Benzoates analog binds to and results in decreased activity of GRIA3 protein CTD PMID:14667236 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GRIA3 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of GRIA3 mRNA CTD PMID:26496021 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GRIA3 mRNA CTD PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GRIA3 mRNA CTD PMID:25181051 , PMID:34947998 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GRIA3 mRNA CTD PMID:33453195 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GRIA3 mRNA CTD PMID:25993096 cannabidiol decreases expression ISO RGD:737336 6480464 Cannabidiol results in decreased expression of GRIA3 mRNA CTD PMID:27714895 carbon nanotube affects expression ISO RGD:737337 6480464 Nanotubes, Carbon affects the expression of GRIA3 mRNA CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of GRIA3 mRNA CTD PMID:19395590 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of GRIA3 mRNA CTD PMID:18500788 celecoxib multiple interactions ISO RGD:737337 6480464 Celecoxib promotes the reaction [Kainic Acid results in decreased expression of GRIA3 mRNA] CTD PMID:21589914 CGP 52608 multiple interactions ISO RGD:737336 6480464 CGP 52608 promotes the reaction [RORA protein binds to GRIA3 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:737336 6480464 [4-(2-(5 more ... CTD PMID:34480604 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GRIA3 mRNA CTD PMID:19440498 chlorpyrifos decreases expression ISO RGD:737337 6480464 Chlorpyrifos results in decreased expression of GRIA3 mRNA CTD PMID:29156651 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GRIA3 mRNA CTD PMID:18668222 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GRIA3 mRNA CTD PMID:17452286 choline multiple interactions ISO RGD:737337 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRIA3 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:737337 6480464 Cisplatin results in increased expression of GRIA3 mRNA CTD PMID:25270620 citalopram affects response to substance ISO RGD:737336 6480464 GRIA3 polymorphism affects the susceptibility to Citalopram CTD PMID:19295509 Citreoviridin increases expression ISO RGD:737337 6480464 citreoviridin results in increased expression of GRIA3 mRNA CTD PMID:30071239 cocaine increases expression ISO RGD:737336 6480464 Cocaine results in increased expression of GRIA3 protein CTD PMID:16363995 cocaine affects expression EXP 6480464 Cocaine affects the expression of GRIA3 protein CTD PMID:12511956 , PMID:15140200 cocaine decreases expression ISO RGD:737337 6480464 Cocaine results in decreased expression of GRIA3 mRNA CTD PMID:9886066 cortisol multiple interactions ISO RGD:737336 6480464 [4-(2-(5 more ... CTD PMID:34480604 crocidolite asbestos decreases expression ISO RGD:737337 6480464 Asbestos, Crocidolite results in decreased expression of GRIA3 mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GRIA3 mRNA CTD PMID:26577399 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of GRIA3 mRNA CTD PMID:23914054 Diacetoxyscirpenol decreases expression ISO RGD:737337 6480464 diacetoxyscirpenol results in decreased expression of GRIA3 mRNA CTD PMID:31836554 dichloroacetic acid decreases expression ISO RGD:737337 6480464 Dichloroacetic Acid results in decreased expression of GRIA3 mRNA CTD PMID:28962523 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of GRIA3 mRNA CTD PMID:21161181 dorsomorphin multiple interactions ISO RGD:737336 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GRIA3 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:737337 6480464 epoxiconazole results in decreased expression of GRIA3 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GRIA3 mRNA CTD PMID:20655511 , PMID:35227807 ethanol affects expression EXP 6480464 Ethanol affects the expression of GRIA3 mRNA CTD PMID:34547370 ethanol multiple interactions ISO RGD:737337 6480464 Ethanol affects the expression of and affects the splicing of GRIA3 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:737337 6480464 Ethanol results in increased expression of GRIA3 mRNA CTD PMID:30319688 etoposide increases expression ISO RGD:737337 6480464 Etoposide results in increased expression of GRIA3 mRNA CTD PMID:25270620 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GRIA3 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:737337 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRIA3 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:737337 6480464 Folic Acid results in decreased expression of GRIA3 mRNA CTD PMID:25629700 fulvestrant decreases methylation ISO RGD:737336 6480464 Fulvestrant results in decreased methylation of GRIA3 gene CTD PMID:31601247 geldanamycin increases expression ISO RGD:737336 6480464 geldanamycin results in increased expression of GRIA3 mRNA CTD PMID:26705709 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of GRIA3 mRNA CTD PMID:32419051 kainic acid decreases expression EXP 6480464 Kainic Acid results in decreased expression of GRIA3 mRNA CTD PMID:7529610 kainic acid multiple interactions ISO RGD:737337 6480464 celecoxib promotes the reaction [Kainic Acid results in decreased expression of GRIA3 mRNA] CTD PMID:21589914 kainic acid decreases expression ISO RGD:737337 6480464 Kainic Acid results in decreased expression of GRIA3 mRNA CTD PMID:21589914 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of GRIA3 mRNA CTD PMID:7529610 L-ascorbic acid multiple interactions ISO RGD:737336 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:737336 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:737337 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRIA3 mRNA CTD PMID:20938992 lead diacetate decreases expression ISO RGD:737337 6480464 lead acetate results in decreased expression of GRIA3 mRNA CTD PMID:24260418 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GRIA3 mRNA CTD PMID:33862172 lipopolysaccharide multiple interactions ISO RGD:737336 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GRIA3 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:737336 6480464 Lipopolysaccharides results in increased expression of GRIA3 mRNA CTD PMID:35811015 lithium atom multiple interactions EXP 6480464 [Lithium co-treated with Pilocarpine] results in decreased expression of GRIA3 mRNA CTD PMID:16819974 lithium hydride multiple interactions EXP 6480464 [Lithium co-treated with Pilocarpine] results in decreased expression of GRIA3 mRNA CTD PMID:16819974 mercury dibromide decreases expression ISO RGD:737336 6480464 mercuric bromide results in decreased expression of GRIA3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737336 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GRIA3 mRNA CTD PMID:18419818 methylmercury chloride decreases expression ISO RGD:737336 6480464 methylmercuric chloride results in decreased expression of GRIA3 mRNA CTD PMID:28001369 mitomycin C increases expression ISO RGD:737337 6480464 Mitomycin results in increased expression of GRIA3 mRNA CTD PMID:25270620 morphine decreases expression EXP 6480464 Morphine results in decreased expression of GRIA3 mRNA CTD PMID:15183518 N-nitrosodiethylamine increases expression ISO RGD:737337 6480464 Diethylnitrosamine results in increased expression of GRIA3 mRNA CTD PMID:21607683 , PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GRIA3 mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of GRIA3 promoter CTD PMID:25374375 nickel atom decreases expression ISO RGD:737336 6480464 Nickel results in decreased expression of GRIA3 mRNA CTD PMID:24768652 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:737336 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of GRIA3 gene CTD PMID:30521419 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of GRIA3 mRNA CTD PMID:11526992 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of GRIA3 mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:737337 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GRIA3 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO RGD:737336 6480464 p-Chloromercuribenzoic Acid results in decreased expression of GRIA3 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:737336 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:737336 6480464 panobinostat results in decreased expression of GRIA3 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:737336 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:737336 6480464 Acetaminophen results in decreased expression of GRIA3 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GRIA3 mRNA CTD PMID:33387578 phenobarbital decreases expression ISO RGD:737337 6480464 Phenobarbital results in decreased expression of GRIA3 mRNA CTD PMID:23091169 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GRIA3 mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of GRIA3 promoter CTD PMID:25374375 phenylmercury acetate decreases expression ISO RGD:737336 6480464 Phenylmercuric Acetate results in decreased expression of GRIA3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737336 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:737337 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GRIA3 mRNA CTD PMID:23519560 pirinixic acid multiple interactions ISO RGD:737336 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GRIA3 mRNA CTD PMID:19710929 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA] CTD PMID:31068541 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA] CTD PMID:31068541 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GRIA3 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737336 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GRIA3 mRNA] CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:737336 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of GRIA3 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:737336 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 senecionine increases expression EXP 6480464 senecionine results in increased expression of GRIA3 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of GRIA3 mRNA CTD PMID:32419051 sterigmatocystin increases expression EXP 6480464 Sterigmatocystin results in increased expression of GRIA3 mRNA CTD PMID:34126181 sulforaphane decreases expression ISO RGD:737337 6480464 sulforaphane results in decreased expression of GRIA3 mRNA CTD PMID:30529165 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GRIA3 mRNA CTD PMID:26496021 thalidomide decreases expression ISO RGD:737336 6480464 Thalidomide results in decreased expression of GRIA3 mRNA CTD PMID:32756504 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GRIA3 mRNA CTD PMID:23411599 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GRIA3 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:737337 6480464 titanium dioxide results in increased expression of GRIA3 mRNA CTD PMID:27760801 toluene affects expression EXP 6480464 Toluene affects the expression of GRIA3 mRNA CTD PMID:21827849 tremolite asbestos decreases expression ISO RGD:737337 6480464 tremolite results in decreased expression of GRIA3 mRNA CTD PMID:29279043 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of GRIA3 mRNA CTD PMID:19591855 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GRIA3 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:737336 6480464 trichostatin A results in decreased expression of GRIA3 mRNA CTD PMID:24935251 trichostatin A increases expression ISO RGD:737336 6480464 trichostatin A results in increased expression of GRIA3 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:737336 6480464 Triclosan results in decreased expression of GRIA3 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:737337 6480464 trimellitic anhydride results in decreased expression of GRIA3 mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:737337 6480464 triptonide results in decreased expression of GRIA3 mRNA CTD PMID:33045310 valproic acid decreases expression ISO RGD:737336 6480464 Valproic Acid results in decreased expression of GRIA3 mRNA CTD PMID:24383497 , PMID:28001369 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GRIA3 mRNA CTD PMID:31085223 valproic acid increases expression ISO RGD:737336 6480464 Valproic Acid results in increased expression of GRIA3 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:737336 6480464 Valproic Acid affects the expression of GRIA3 mRNA CTD PMID:25979313 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of GRIA3 mRNA CTD PMID:25423262 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GRIA3 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of GRIA3 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:737336 6480464 vorinostat results in increased expression of GRIA3 mRNA CTD PMID:27188386 XAV939 multiple interactions ISO RGD:737336 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA CTD PMID:34480604
